Zeng, H.; Dumitrescu, A.V.; Wadkins, D.; Elwood, B.W.; Gramlich, O.W.; Kuehn, M.H.
Systemic Treatment with Pioglitazone Reverses Vision Loss in Preclinical Glaucoma Models. Biomolecules 2022, 12, 281.
https://doi.org/10.3390/biom12020281
AMA Style
Zeng H, Dumitrescu AV, Wadkins D, Elwood BW, Gramlich OW, Kuehn MH.
Systemic Treatment with Pioglitazone Reverses Vision Loss in Preclinical Glaucoma Models. Biomolecules. 2022; 12(2):281.
https://doi.org/10.3390/biom12020281
Chicago/Turabian Style
Zeng, Huilan, Alina V. Dumitrescu, David Wadkins, Benjamin W. Elwood, Oliver W. Gramlich, and Markus H. Kuehn.
2022. "Systemic Treatment with Pioglitazone Reverses Vision Loss in Preclinical Glaucoma Models" Biomolecules 12, no. 2: 281.
https://doi.org/10.3390/biom12020281
APA Style
Zeng, H., Dumitrescu, A. V., Wadkins, D., Elwood, B. W., Gramlich, O. W., & Kuehn, M. H.
(2022). Systemic Treatment with Pioglitazone Reverses Vision Loss in Preclinical Glaucoma Models. Biomolecules, 12(2), 281.
https://doi.org/10.3390/biom12020281